GPP
Great Point Partners’s UroGen Pharma URGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-187,843
| Closed | -$2M | – | 35 |
|
|
2024
Q4 | $2M | Sell |
187,843
-570,943
| -75% | -$6.08M | 0.94% | 26 |
|
|
2024
Q3 | $9.64M | Sell |
758,786
-2,147,473
| -74% | -$27.3M | 2.84% | 16 |
|
|
2024
Q2 | $48.8M | Buy |
2,906,259
+285,714
| +11% | +$4.79M | 9.34% | 1 |
|
|
2024
Q1 | $39.3M | Hold |
2,620,545
| – | – | 6.13% | 3 |
|
|
2023
Q4 | $39.3M | Hold |
2,620,545
| – | – | 6.7% | 3 |
|
|
2023
Q3 | $36.7M | Buy |
+2,620,545
| New | +$36.7M | 6.69% | 1 |
|
|
2023
Q2 | – | Sell |
-39,222
| Closed | -$362K | – | 48 |
|
|
2023
Q1 | $362K | Sell |
39,222
-520,778
| -93% | -$4.81M | 0.07% | 42 |
|
|
2022
Q4 | $4.97M | Sell |
560,000
-313,424
| -36% | -$2.78M | 0.97% | 33 |
|
|
2022
Q3 | $7.27M | Hold |
873,424
| – | – | 1.75% | 21 |
|
|
2022
Q2 | $7.15M | Hold |
873,424
| – | – | 1.72% | 22 |
|
|
2022
Q1 | $7.61M | Hold |
873,424
| – | – | 1.84% | 21 |
|
|
2021
Q4 | $8.31M | Buy |
873,424
+123,424
| +16% | +$1.17M | 1.85% | 24 |
|
|
2021
Q3 | $12.6M | Buy |
+750,000
| New | +$12.6M | 2.94% | 14 |
|